Cha Jooyoung of "The Glory" Temporarily Halts Activities Due to Health Issues
Agency: "Underwent Surgery for Recurrent Symptoms"
Disruptions to "Sister" Film Promotions and Other Schedules
Actress Cha Jooyoung, who rose to stardom through Netflix's "The Glory," is temporarily suspending her activities due to health reasons.
Her agency, Ghost Studio, announced on January 26, "Due to health issues, Cha Jooyoung will not be able to attend her scheduled official events and some activities for the time being."
Recently, Cha Jooyoung visited the hospital after experiencing prolonged and recurrent nosebleeds. Based on the medical team's opinion, she underwent surgery in the otolaryngology department. The agency explained, "She is currently in a stage where recovery and observation are necessary," and added, "She plans to focus on treatment and take a break for the time being."
This suspension of activities is expected to cause some disruptions to her upcoming projects. Cha Jooyoung starred in the film "Sister," which is set to be released on January 28, as well as the ENA drama "Climax," scheduled to air in March. For "Sister," which is about to premiere, her participation in promotional activities, including stage greetings, has become uncertain.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The agency added, "This decision was made with the actor's health as the top priority," and stated, "She will greet everyone again in good health after receiving sufficient treatment."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.